Cabazitaxel 2-Propanol Solvate — Drug Intelligence | 2 EU Trials

Filter these 2 trials by condition, phase, country and more.

2 Registered trials

2 Recruiting

0 Completed trials

2 Sponsors

8 Countries

Phase II

Phase I/II

Phase II: 1 Phase I/II: 1

Oversight events:

8 temporary halts 1 urgent safety measure across 2 trials

Indications tested

2 total

Darolutamide and bipolar androgen therapy for mCRPC patients (DaroBAT) Recruiting

2025-521051-23-00 Phase II 1 country Universitaet Muenster
Study of MK-5684-based Therapies in Advanced Prostate Cancer Recruiting

2023-506288-33-00 Phase I/II 8 countries Merck Sharp & Dohme LLC

Showing 1–2 of 2 trials